Use of baculovirus BacMam vectors for expression of ABC drug transporters in mammalian cells

Drug Metabolism and Disposition

Volumn 40, Issue 2, 2012, Pages 304-312

  Shukla, Suneet ^a   Schwartz, Candice ^a   Kapoor, Khyati ^a   Kouanda, Abdul ^a   Ambudkar, Suresh V ^a  

^a NATIONAL CANCER INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ABC TRANSPORTER; ADENOSINE TRIPHOSPHATE; BACULOVIRUS VECTOR; BREAST CANCER RESISTANCE PROTEIN; GLYCOPROTEIN P;

ANIMAL CELL; ARTICLE; BACULOVIRUS EXPRESSION SYSTEM; CELL SURFACE; CONTROLLED STUDY; CROSS LINKING; DRUG TRANSPORT; GENETIC TRANSDUCTION; HELA CELL; HUMAN; HUMAN CELL; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION;

ANIMALS; ANTINEOPLASTIC AGENTS; ATP-BINDING CASSETTE TRANSPORTERS; BACULOVIRIDAE; BIOLOGICAL TRANSPORT; CELL LINE, TUMOR; CELL MEMBRANE; CHLOROPHYLL; DOXORUBICIN; DRUG EVALUATION, PRECLINICAL; DRUG RESISTANCE, NEOPLASM; GENETIC VECTORS; HUMANS; MAMMALS; MITOXANTRONE; NEOPLASM PROTEINS; NEOPLASMS; P-GLYCOPROTEIN; RADIATION-SENSITIZING AGENTS; RECOMBINANT PROTEINS; TRANSDUCTION, GENETIC;

MAMMALIA;

EID: 84855998504     PISSN: 00909556     EISSN: 1521009X     Source Type: Journal    
DOI: 10.1124/dmd.111.042721     Document Type: Article

References (33)

1. Ambudkar SV (1998) Drug-stimulatable ATPase activity in crude membranes of human MDR1-transfected mammalian cells. Methods Enzymol 292:504-514.
2. Arrowsmith J (2011) Trial watch: phase II failures: 2008-2010. Nat Rev Drug Discov 10:328-329.
3. Barsoum J, Brown R, McKee M, and Boyce FM (1997) Efficient transduction of mammalian cells by a recombinant baculovirus having the vesicular stomatitis virus G glycoprotein. Hum Gene Ther 8:2011-2018.
4. Borst P and Elferink RO (2002) Mammalian ABC transporters in health and disease. Annu Rev Biochem 71:537-592. (Pubitemid 34800230)
5. Calcagno AM, Kim IW, Wu CP, Shukla S, and Ambudkar SV (2007) ABC drug transporters as molecular targets for the prevention of multidrug resistance and drug-drug interactions. Curr Drug Deliv 4:324-333. (Pubitemid 47549498)
6. Condreay JP, Witherspoon SM, Clay WC, and Kost TA (1999) Transient and stable gene expression in mammalian cells transduced with a recombinant baculovirus vector. Proc Natl Acad Sci USA 96:127-132. (Pubitemid 29036064)
7. El-Sheikh AA, van den Heuvel JJ, Krieger E, Russel FG, and Koenderink JB (2008) Functional role of arginine 375 in transmembrane helix 6 of multidrug resistance protein 4 (MRP4/ABCC4). Mol Pharmacol 74:964-971.
8. Englund G, Rorsman F, Rönnblom A, Karlbom U, Lazorova L, Gråsjö J, Kindmark A, and Artursson P (2006) Regional levels of drug transporters along the human intestinal tract: co-expression of ABC and SLC transporters and comparison with Caco-2 cells. Eur J Pharm Sci 29:269-277. (Pubitemid 44602404)
9. Glavinas H, Krajcsi P, Cserepes J, and Sarkadi B (2004) The role of ABC transporters in drug resistance, metabolism and toxicity. Curr Drug Deliv 1:27-42.
10. Glavinas H, Méhn D, Jani M, Oosterhuis B, Herédi- Szabó K, and Krajcsi P (2008) Utilization of membrane vesicle preparations to study drug-ABC transporter interactions. Expert Opin Drug Metab Toxicol 4:721-732. (Pubitemid 352003195)
11. Gribar JJ, Ramachandra M, Hrycyna CA, Dey S, and Ambudkar SV (2000) Functional characterization of glycosylation-deficient human P-glycoprotein using a vaccinia virus expression system. J Membr Biol 173:203-214. (Pubitemid 30100212)
12. Hamada H and Tsuruo T (1986) Functional role for the 170- to 180-kDa glycoprotein specific to drug-resistant tumor cells as revealed by monoclonal antibodies. Proc Natl Acad Sci USA 83:7785-7789. (Pubitemid 17183929)
13. Hassan NJ, Pountney DJ, Ellis C, and Mossakowska DE (2006) BacMam recombinant baculovirus in transporter expression: a study of BCRP and OATP1B1. Protein Expr Purif 47:591-598. (Pubitemid 43729033)
14. Kartner N, Evernden-Porelle D, Bradley G, and Ling V (1985) Detection of P-glycoprotein in multidrug-resistant cell lines by monoclonal antibodies. Nature 316:820-823. (Pubitemid 15003741)
15. Kerr KM, Sauna ZE, and Ambudkar SV (2001) Correlation between steady-state ATP hydrolysis and vanadate-induced ADP trapping in Human P-glycoprotein. Evidence for ADP release as the rate-limiting step in the catalytic cycle and its modulation by substrates. J Biol Chem 276:8657-8664.
16. Kost TA, Condreay JP, Ames RS, Rees S, and Romanos MA (2007) Implementation of BacMam virus gene delivery technology in a drug discovery setting. Drug Discov Today 12:396-403. (Pubitemid 46646990)
17. Kost TA, Condreay JP, and Jarvis DL (2005) Baculovirus as versatile vectors for protein expression in insect and mammalian cells. Nat Biotechnol 23:567-575. (Pubitemid 41724895)
18. Lai Y, Sampson KE, and Stevens JC (2010) Evaluation of drug transporter interactions in drug discovery and development. Comb Chem High Throughput Screen 13:112-134.
19. Maliepaard M, Scheffer GL, Faneyte IF, van Gastelen MA, Pijnenborg AC, Schinkel AH, van De Vijver MJ, Scheper RJ, and Schellens JH (2001) Subcellular localization and distribution of the breast cancer resistance protein transporter in normal human tissues. Cancer Res 61:3458-3464. (Pubitemid 32695041)
20. Mutsaers HA, van den Heuvel LP, Ringens LH, Dankers AC, Russel FG, Wetzels JF, Hoenderop JG, and Masereeuw R (2011) Uremic toxins inhibit transport by breast cancer resistance protein and multidrug resistance protein 4 at clinically relevant concentrations. PLoS One 6:e18438.
21. Ozvegy-Laczka C, Várady G, Köblös G, Ujhelly O, Cervenak J, Schuetz JD, Sorrentino BP, Koomen GJ, Váradi A, Német K, et al. (2005) Function-dependent conformational changes of the ABCG2 multidrug transporter modify its interaction with a monoclonal antibody on the cell surface. J Biol Chem 280:4219-4227. (Pubitemid 40288588)
22. Pál A, Méhn D, Molnár E, Gedey S, Mészáros P, Nagy T, Glavinas H, Janáky T, von Richter O, Báthori G, et al. (2007) Cholesterol potentiates ABCG2 activity in a heterologous expression system: improved in vitro model to study function of human ABCG2. J Pharmacol Exp Ther 321:1085-1094. (Pubitemid 46762703)
23. Poller B, Wagenaar E, Tang SC, and Schinkel AH (2011) Double-transduced MDCKII cells to study human P-glycoprotein (ABCB1) and breast cancer resistance protein (ABCG2) interplay in drug transport across the blood-brain barrier. Mol Pharm 8:571-582.
24. Robey RW, Medina-Pérez WY, Nishiyama K, Lahusen T, Miyake K, Litman T, Senderowicz AM, Ross DD, and Bates SE (2001) Overexpression of the ATP-binding cassette half-transporter, ABCG2 (Mxr/BCrp/ABCP1), in flavopiridol-resistant human breast cancer cells. Clin Cancer Res 7:145-152. (Pubitemid 32110217)
25. Robey RW, Steadman K, Polgar O, Morisaki K, Blayney M, Mistry P, and Bates SE (2004) Pheophorbide a is a specific probe for ABCG2 function and inhibition. Cancer Res 64:1242-1246. (Pubitemid 38235589)
26. Sauna ZE, Müller M, Peng XH, and Ambudkar SV (2002) Importance of the conserved Walker B glutamate residues, 556 and 1201, for the completion of the catalytic cycle of ATP hydrolysis by human P-glycoprotein (ABCB1). Biochemistry 41:13989-14000. (Pubitemid 35364871)
27. Shen DW, Cardarelli C, Hwang J, Cornwell M, Richert N, Ishii S, Pastan I, and Gottesman MM (1986) Multiple drug-resistant human KB carcinoma cells independently selected for highlevel resistance to colchicine, adriamycin, or vinblastine show changes in expression of specific proteins. J Biol Chem 261:7762-7770. (Pubitemid 17208699)
28. Shukla S, Robey RW, Bates SE, and Ambudkar SV (2006) The calcium channel blockers, 1,4-dihydropyridines, are substrates of the multidrug resistance-linked ABC drug transporter, ABCG2. Biochemistry 45:8940-8951. (Pubitemid 44100690)
29. Strober W (2001) Trypan blue exclusion test of cell viability. Curr Protoc Immunol Appendix 3:Appendix 3B.
30. Szakács G, Váradi A, Ozvegy-Laczka C, and Sarkadi B (2008) The role of ABC transporters in drug absorption, distribution, metabolism, excretion and toxicity (ADME-Tox). Drug Discov Today 13:379-393.
31. Thiebaut F, Tsuruo T, Hamada H, Gottesman MM, Pastan I, and Willingham MC (1987) Cellular localization of the multidrug-resistance gene product P-glycoprotein in normal human tissues. Proc Natl Acad Sci USA 84:7735-7738.
32. Tiberghien F and Loor F (1996) Ranking of P-glycoprotein substrates and inhibitors by a calcein-AM fluorometry screening assay. Anticancer Drugs 7:568-578. (Pubitemid 26276348)
33. Tsaioun K, Bottlaender M, Mabondzo A, and Alzheimer's Drug Discovery Foundation (2009) ADDME - Avoiding Drug Development Mistakes Early: central nervous system drug discovery perspective. BMC Neurol 9 (Suppl 1):S1.